Surgery Partners Inc (NASDAQ: SGRY) has reported a loss for its second fiscal quarter (ending June 30) of $-0.12 versus $0.15 for the same period a year ago — a decline of -180%. This result fell short of the consensus estimate of $0.20 by $-0.32. For the latest four quarters through June 30, E.P.S. were $-0.27 versus $-0.56 for the same period a year ago.
Recent Price Action
Surgery Partners Inc (NASDAQ: SGRY) stock enjoyed a large increase of 3.2% on 8/6/24. The stock closed at $29.64. Moreover, trading volume in this advance was unusually high at 162% of normal. The stock has been weak relative to the market over the last nine months and has declined -4.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, SGRY is expected to continue to be a modest Value Builder.
Surgery Partners has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Surgery Partners has a neutral Appreciation Score of 58 but a poor Power Rating of 20, leading to the Negative Value Trend Rating.
Rating Review
In light of this discouraging new earnings information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment